DARA BioSciences is a specialty pharmaceutical company engaged in developing and commercializing oncology treatment and supportive care products. Through agreements with various entities, the company has comprehensive commercial coverage across the national oncology market. DARA is part of an integrated national network with yearly sales of more than $1 billion in cancer therapeutics, and its distribution network consists of more than 45,000 retail pharmacies, mail order pharmacies and long-term care facilities. For more information, visit the company’s Web site at www.darabio.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: